Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01615432
Other study ID # Synchro_Non invasive vent
Secondary ID
Status Completed
Phase N/A
First received June 6, 2012
Last updated May 15, 2013
Start date June 2012
Est. completion date April 2013

Study information

Verified date May 2013
Source University of Lausanne Hospitals
Contact n/a
Is FDA regulated No
Health authority Switzerland: Laws and standardsSwitzerland: Ethikkommission
Study type Interventional

Clinical Trial Summary

Comparison of the effects of 4 ventilators dedicated to NIV (2 home ventilators and 2 ventilators designed for NIV) on patient-ventilator synchrony and comfort in patients admitted in the intensive care unit for respiratory failure and treated with NIV.


Recruitment information / eligibility

Status Completed
Enrollment 22
Est. completion date April 2013
Est. primary completion date November 2012
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- respiratory failure

Exclusion Criteria:

- Severe hypoxemia requiring an FiO2 > 0.6

- Hemodynamic instability : defined as a variation of > 20% in mean arterial pressure (MAP) and heart rate (HR) during the previous 2 hours; the need for high doses of catecholamines (namely > 0.5 mcg/kg/min) and/or the need of major volume resuscitation (more than 2 liters of fluids in 2 hours)

- Impaired consciousness or absence of patient cooperation;

- Facial or laryngeal lesions contraindicating the use of NIV;

- Poor short term prognosis.

- Age < 18 years old

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms

  • Respiratoy Failure Requiring NIV Treatment

Intervention

Device:
V-PAP III ventilator

Stellar 150 ventilator

BiPAP vision ventilator

V60 ventilator


Locations

Country Name City State
Switzerland Intensive care and burn unit / CHUV Lausanne Vaud

Sponsors (1)

Lead Sponsor Collaborator
University of Lausanne Hospitals

Country where clinical trial is conducted

Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Patient-ventilator synchrony Patient-ventilator synchrony will be assessed breath by brath on the basis of airway pressure, flow and diaphragmatic electrical activity recordings. No
Secondary comfort of patient under NIV Patient's confort during NIV will be assessed using a visual analogic scale. No
Secondary Ventilatory parameters Tidal volume, respiratory rate, inspiratory time, expiratory time and maximal and mean airway pressure will be measured from the continuous recording of airway pressure and flow. No